Production (Stage)
VentriPoint Diagnostics Ltd.
VPT.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 17.48% | 11.57% | -17.58% | 2.98% | -3.86% |
| Total Depreciation and Amortization | -3.51% | -0.87% | -4.17% | -1.64% | -0.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -97.32% | 402.60% | 86.12% | -45.76% | -8.12% |
| Change in Net Operating Assets | 961.18% | -118.65% | -22.86% | 109.95% | 73.31% |
| Cash from Operations | -1.62% | 37.02% | -24.22% | 11.15% | -0.77% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -16.67% | -73.33% | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 57.64% | -136.05% | -10.11% |
| Issuance of Common Stock | 109.55% | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -45.63% | 21.04% | -- | -- | -- |
| Cash from Financing | 41.04% | -52.70% | 3,308.90% | -9.26% | -8.54% |
| Foreign Exchange rate Adjustments | -557.89% | 267.65% | 67.92% | -219.10% | 221.92% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 74.95% | -181.85% | 92.56% | 8.06% | 1.17% |